Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities
Chang Xu, Kie Kyon Huang, Jia Hao Law, et al.
Gut (2023) Vol. 72, Iss. 9, pp. 1651-1663
Closed Access | Times Cited: 19

Showing 19 citing articles:

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression
Kie Kyon Huang, Haoran Ma, Roxanne Hui Heng Chong, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2019-2037.e8
Open Access | Times Cited: 37
Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer
Milad Razavi-Mohseni, Weitai Huang, Yu Amanda Guo, et al.
Genome Research (2024) Vol. 34, Iss. 5, pp. 680-695
Open Access | Times Cited: 6
Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment
Chao Deng, Zi-xi Li, Chen-jun Xie, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy
Jiao Xu, Bixin Yu, Fan Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 4
Identification of Prognosis Signature Based on cGAS-STING Pathway and Its Immunotherapeutic Significance in Lung Adenocarcinoma
Xiao Ling Huang, Xuefeng Lv, Xinghua Cao
Molecular Biotechnology (2025)
Closed Access
Non-local modeling of enhancer-promoter interactions, a correspondence on “LOCO-EPI: Leave-one-chromosome-out (LOCO) as a benchmarking paradigm for deep learning based prediction of enhancer-promoter interactions”
M Beer
Applied Intelligence (2025) Vol. 55, Iss. 6
Closed Access
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Gastric Cardiac Carcinoma: Recent Progress in Clinicopathology, Prognosis, and Early Diagnosis
Qin Huang, Yu Qing Cheng, K. Hu, et al.
Journal of Digestive Diseases (2025)
Closed Access
Single-Cell Pharmacogenomic Landscapes of Epigenetic Therapy in Gastric Cancer
Chang Xu, Haoran Ma, Taotao Sheng, et al.
(2025)
Closed Access
Super-enhancers: Implications in gastric cancer
Yizhou Huang, Yanfei Huo, Linying Huang, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 793, pp. 108489-108489
Closed Access | Times Cited: 2
MicroRNAs provide negative feedback and stability in gene regulatory network models of cell-state transitions
Milad Razavi-Mohseni, M Beer
Frontiers in Epigenetics and Epigenomics (2024) Vol. 2
Open Access | Times Cited: 2
Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma
Inwoo Hwang, Yunjoo Cho, So Young Kang, et al.
Pathology - Research and Practice (2024), pp. 155063-155063
Open Access | Times Cited: 1
Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties
Guiqun Yang, Yiwei Lin, Xin Sun, et al.
ACS Omega (2024) Vol. 9, Iss. 19, pp. 21416-21425
Open Access | Times Cited: 1
The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer
Shanshan Yu, Ming Chen, Xiaohua Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34317-e34317
Open Access | Times Cited: 1
Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient germinal center B cell responses
Ajay Abraham, Daniela Samaniego‐Castruita, Isabella Han, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1704-1717
Closed Access | Times Cited: 1
Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient Germinal Center B cell responses
Ajay Abraham, Daniela Samaniego‐Castruita, Jillian Paladino, et al.
Research Square (Research Square) (2024)
Open Access
Which occurs first, ARID1A inactivation or microsatellite instability?: A comment to Yamamoto et al. (2024)
Dakeun Lee
Cancer Science (2024) Vol. 115, Iss. 10, pp. 3488-3490
Open Access
VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinoma
Dong Wu, Kangliang Zhang, Rui-heng Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Spatial Profiling of Patient-Matched HER2 Positive Gastric Cancer Reveals Resistance Mechanisms to Trastuzumab and Trastuzumab Deruxtecan
Taotao Sheng, Raghav Sundar, Supriya Srivastava, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dual roles of ARID1A in both mucin production and secretion suggest susceptibilities of gastric signet ring cell carcinoma
Chong Chen, Hongyu Liu, Ailing Zhong, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top